Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-12-224070
Filing Date
2012-05-10
Accepted
2012-05-10 10:18:27
Documents
4
Period of Report
2011-12-20
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A d347679d8ka.htm 8-K/A 24893
2 CONSENT OF ERNST & YOUNG AB d347679dex231.htm EX-23.1 1767
3 NOVOZYMES BIOMANUFACTURING BUSINESS COMBINED FINANCIAL STATEMENTS d347679dex992.htm EX-99.2 418211
4 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL STATEMENTS d347679dex993.htm EX-99.3 168840
  Complete submission text file 0001193125-12-224070.txt   614875
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Filer) CIK: 0000730272 (see all company filings)

EIN.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-14656 | Film No.: 12828160
SIC: 2836 Biological Products, (No Diagnostic Substances)